Women are more likely than men to skip, delay or under-take medications because of cost, the Centers for Disease Control and Prevention reported Friday.
The finding came from the CDC National Survey of Health Interviewsan annual survey asking tens of thousands of people in the US about their health-related experiences.
It found that in 2021, 9.2 million adults ages 18 to 64—about 1 in 10—reported skipping, delaying, or using fewer medications than prescribed in the past year to save money. Women outperformed men when it came to this non-compliance: 9.1% vs. 7%.
“I wasn’t surprised by the findings, but they are discouraging,” said Robin Feldman, an expert in pharmaceutical and intellectual property law at the University of California, San Francisco (formerly the University of California, Hastings) School of Law. “Women today still bear a greater share of the burden of childcare and household management. They may make their own health a lower priority, in the face of financial or time pressures,” said Feldman, who was not involved in the survey.
Stacie Dusetzina, a professor of health policy at Vanderbilt University in Nashville, Tennessee, said the gender gap could also be due to the fact that women under 65 tend to take more medications or are more likely to take them than men. men.
However, Dusetzina pointed to another potential factor: “We know that women tend to have lower incomes than men.”
Not taking medications as prescribed can “worsen health conditions, lead to more serious illness and lead to additional costly treatment,” said Eric Tichy, pharmacist and president of the Mayo Clinic pharmaceutical supply solutions division. “It really is a vicious cycle.”
More than half of adults ages 18 to 64 in the US take at least one prescription drug, according to the CDC.
The CDC survey also found that adults with disabilities were more likely than adults without disabilities to skip, delay, or take fewer medications to reduce cost. People in fair or poor health were nearly three times as likely to do so than those in excellent or very good health.
In addition, uninsured adults were more likely than those with insurance not to take their medications due to cost, as were black and non-white Hispanic adults, compared to white and Asian adults.
Robin Cohen, a CDC statistician who co-authored the study, noted that the report doesn’t look at what prescriptions people are taking or for what conditions. It also only looked at people who did not adhere to the drugs due to cost.
“So there may be other reasons why people don’t take the drugs as prescribed, but we didn’t test them,” he said.
The Inflation Reduction Act, enacted last year, aims to lower the cost of prescription drugs for people in the US, but most of the savings will likely go to adults 65 and older, he said Inma Hernandez, associate professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences.
Hernandez said it’s possible that a provision in the law that penalizes drugmakers that raise drug prices faster than inflation could help adults younger than 65. That provision goes into effect in 2024.
“There may be some indirect effects,” he said.
In the meantime, more may need to be done, Feldman said. Last year, billionaire investor Mark Cuban launched the Mark Cuban Cost Plus Drug Co., which offers some generic drugs at reduced prices. California has also announced plans to make its own low-cost insulin. It will partner with Civica Rx, a not-for-profit generic drug company.
“There is a lot of work to be done to bring sanity to drug prices,” Feldman said.

